Join
Live feed
·
INSIDERFilingvia Quantisnow
Ginkgo Bioworks Holdings Inc. logo

Director Kosuri Sri converted options into 24,067 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DNA· Ginkgo Bioworks Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNA (Ginkgo Bioworks Holdings Inc.) and more on Quantisnow.